AI assistant
CUFE LTD — Director's Dealing 2026
Feb 9, 2026
64723_rns_2026-02-09_80d58061-ef8e-4391-a544-f7248121879f.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name of entity | CUFE LIMITED |
|---|---|
| ABN | 31 112 731 638 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director ANTONY WILLIAM PAUL SAGE Date of last notice 4 December 2025
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Indirect (1) EGAS Superannuation Fund (of which Mr Sage is a beneficiary) Indirect (2) Okewood Pty Ltd (a company of which Mr Sage is a director) |
| Date of change | 10 February 2026 |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to change | Indirect (1) 24,923,010 Ordinary Fully Paid Shares 2,000,000 Listed Options (ASX:CUFO) ($0.025 each, expiring 13 June 2027) Indirect (2) 33,913,440 Ordinary Fully Paid Shares 5,000,000 Performance Rights (Tranche 1) (expiring 31 December 2026) 5,000,000 Performance Rights (Tranche 2) (expiring 31 December 2026) 10,000,000 Performance Rights (Tranche 3) (expiring 31 December 2026) |
|---|---|
| Class | (a) Ordinary Shares (b) Performance Rights (Tranche 1) (expiring 31 December 2026) |
| Number acquired | (a) 5,000,000 |
| Number disposed | (b) 5,000,000 |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
Value of shares acquired upon conversion of performance rights is $0.048/share (based on the last closing share price on 9 February 2026) (non-cash). |
| No. of securities held after change | Indirect (1) 24,923,010 Ordinary Fully Paid Shares 2,000,000 Listed Options (ASX:CUFO) ($0.025 each, expiring 13 June 2027) Indirect (2) 38,913,440 Ordinary Fully Paid Shares 5,000,000 Performance Rights (Tranche 2) (expiring 31 December 2026) 10,000,000 Performance Rights (Tranche 3) (expiring 31 December 2026) |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back |
Shares acquired upon conversion of Performance Rights. |
|---|---|
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract N/A Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change
Part 3 –[+] Closed period
Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance No was required? If so, was prior written clearance provided to allow the trade to N/A proceed during this period? If prior written clearance was provided, on what date was this N/A provided?
Released: 10 February 2026
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 3